f Unlocking New Potential: Drug Repurposing and Innovative Pharmaceutics

References

1. NaylorD.M. KauppiD. SchonfeldJ. Therapeutic drug repurposing, repositioning and rescue.Drug Discovery201557
   [Google Scholar]
2. LuoH. LiM. YangM. WuF.X. LiY. WangJ. Biomedical data and computational models for drug repositioning: A comprehensive review.Brief. Bioinform.20212221604161910.1093/bib/bbz17632043521
   [Google Scholar]
3. KaleV.P. Old drugs, new uses: Drug repurposing in hematological malignancies.Seminars in cancer biology.Elsevier202110.1016/j.semcancer.2020.03.005
   [Google Scholar]
4. ReddyD.S. SinhaA. KumarA. SainiV.K. Drug re‐engineering and repurposing: A significant and rapid approach to tuberculosis drug discovery.Arch. Pharm.202235511220021410.1002/ardp.20220021435841594
   [Google Scholar]
5. ThangamaniS. MohammadH. YounisW. SeleemM. Drug repurposing for the treatment of staphylococcal infections.Curr. Pharm. Des.201521162089210010.2174/138161282166615031010441625760334
   [Google Scholar]
6. ScorzoniL. FuchsB.B. JunqueiraJ.C. MylonakisE. Current and promising pharmacotherapeutic options for candidiasis.Expert Opin. Pharmacother.202122788788810.1080/14656566.2021.187395133538201
   [Google Scholar]
7. LiuY. TongZ. ShiJ. LiR. UptonM. WangZ. Drug repurposing for next-generation combination therapies against multidrug-resistant bacteria.Theranostics202111104910492810.7150/thno.5620533754035
   [Google Scholar]
8. DotoloS. MarabottiA. FacchianoA. TagliaferriR. A review on drug repurposing applicable to COVID-19.Brief. Bioinform.202122272674110.1093/bib/bbaa28833147623
   [Google Scholar]
9. ŁoczechinA. SéronK. BarrasA. GiovanelliE. BelouzardS. ChenY.T. Metzler-NolteN. BoukherroubR. DubuissonJ. SzuneritsS. Functional carbon quantum dots as medical countermeasures to human coronavirus.ACS Appl. Mater. Interfaces20191146429644297410.1021/acsami.9b1503231633330
   [Google Scholar]
10. NwekeE.E. RajT.G.D.B. Drug sensitivity and drug repurposing platform for cancer precision medicine.In: Cell Biology and Translational Medicine, Volume 12: Stem Cells in Development and Disease2021475310.1007/5584_2021_622
    [Google Scholar]
11. PushpakomS. IorioF. EyersP.A. EscottK.J. HopperS. WellsA. DoigA. GuilliamsT. LatimerJ. McNameeC. NorrisA. SanseauP. CavallaD. PirmohamedM. Drug repurposing: Progress, challenges and recommendations.Nat. Rev. Drug Discov.2019181415810.1038/nrd.2018.16830310233
    [Google Scholar]
12. ParvathaneniV. KulkarniN.S. MuthA. GuptaV. Drug repurposing: A promising tool to accelerate the drug discovery process.Drug Discov. Today201924102076208510.1016/j.drudis.2019.06.01431238113
    [Google Scholar]
13. MolinaM.D. NordlundP. The cellular thermal shift assay: A novel biophysical assay for in situ drug target engagement and mechanistic biomarker studies.Annu. Rev. Pharmacol. Toxicol.201656114116110.1146/annurev‑pharmtox‑010715‑10371526566155
    [Google Scholar]
14. WuZ. WangY. ChenL. Network-based drug repositioning.Mol. Biosyst.2013961268128110.1039/c3mb25382a23493874
    [Google Scholar]
15. TanG.S.Q. SloanE.K. LambertP. KirkpatrickC.M.J. IlomäkiJ. Drug repurposing using real-world data.Drug Discov. Today202328110342210.1016/j.drudis.2022.10342236341896
    [Google Scholar]
16. ShinozakiA. Electronic medical records and machine learning in approaches to drug development.Artificial intelligence in Oncology drug discovery and development.IntechOpen202010.5772/intechopen.92613
    [Google Scholar]
17. RudrapalM. KhairnarS.J. JadhavA.G. Drug Repurposing (DR): An emerging approach in drug discovery.In: Drug repurposing-hypothesis, molecular aspects and therapeutic applicationsIntechOpen2020
    [Google Scholar]
18. Pessoa-AmorimG. CampbellM. FletcherL. HorbyP. LandrayM. MafhamM. HaynesR. Making trials part of good clinical care: Lessons from the RECOVERY trial.Future Healthc. J.202182e243e25010.7861/fhj.2021‑008334286192
    [Google Scholar]
19. KohH.W.L. FerminD. VogelC. ChoiK.P. EwingR.M. ChoiH. iOmicsPASS: Network-based integration of multiomics data for predictive subnetwork discovery.NPJ Syst. Biol. Appl.2019512210.1038/s41540‑019‑0099‑y31312515
    [Google Scholar]
20. BookmanR.J. CiminoJ.J. HarleC.A. KostR.G. MooneyS. PfaffE. RojevskyS. TobinJ.N. WilcoxA. TsinoremasN.F. Research informatics and the COVID-19 pandemic: Challenges, innovations, lessons learned, and recommendations.J. Clin. Transl. Sci.202151e11010.1017/cts.2021.2634192063
    [Google Scholar]
21. AllarakhiaM. Open-source approaches for the repurposing of existing or failed candidate drugs: Learning from and applying the lessons across diseases.Drug Des. Devel. Ther.2013775376610.2147/DDDT.S4628923966771
    [Google Scholar]
22. BegleyC.G. AshtonM. BaellJ. BettessM. BrownM.P. CarterB. CharmanW.N. DavisC. FisherS. FrazerI. GautamA. JenningsM.P. KearneyP. KeeffeE. KellyD. LopezA.F. McGuckinM. ParkerM.W. RaynerC. RobertsB. RushJ.S. SullivanM. Drug repurposing: Misconceptions, challenges, and opportunities for academic researchers.Sci. Transl. Med.202113612eabd552410.1126/scitranslmed.abd552434550729
    [Google Scholar]
23. HalabiS.F. The drug repurposing ecosystem: Intellectual property incentives, market exclusivity, and the future of new medicines.Yale JL & Tech.2018201
    [Google Scholar]
24. MohapatraT.K. SubudhiB.B. Repurposing of aspirin: Opportunities and challenges.Res J Pharm Technol.20191242037204410.5958/0974‑360X.2019.00337.8
    [Google Scholar]
25. AhmedZ.S.O. GolovoyM. AbdullahY. AhmedR.S.I. DouQ.P. Repurposing of metformin for cancer therapy: Updated patent and literature review.Recent Pat Anticancer Drug Discov.202116216118610.2174/157489281666621061516341734132186
    [Google Scholar]
26. PoitrasE.L. GustS.L. KerrP.M. PlaneF. Repurposing of the PDE5 inhibitor sildenafil for the treatment of persistent pulmonary hypertension in neonates.Curr. Med. Chem.202128122418243710.2174/092986732766620092315192432964819
    [Google Scholar]
27. ScheinC.H. Repurposing approved drugs for cancer therapy.Br. Med. Bull.20211371132710.1093/bmb/ldaa04533517358
    [Google Scholar]
28. AwadH. HassanB. DweekS. AboelataY. Rawas-QalajiM. AhmedI.S. Repurposing potential of the antiparasitic agent ivermectin for the treatment and/or prophylaxis of COVID-19.Pharmaceuticals2022159106810.3390/ph1509106836145289
    [Google Scholar]
29. JordanV. New insights into the metabolism of tamoxifen and its role in the treatment and prevention of breast cancer.Steroids2007721382984210.1016/j.steroids.2007.07.00917765940
    [Google Scholar]
30. CuestaA.M. Gallardo-VaraE. Casado-VelaJ. Recio-PovedaL. BotellaL.M. AlbiñanaV. The role of propranolol as a repurposed drug in rare vascular diseases.Int. J. Mol. Sci.2022238421710.3390/ijms2308421735457036
    [Google Scholar]
31. PatelK. WaldronD. GrazianeN. Re-purposing FDA-approved drugs for opioid use disorder.Subst. Use Misuse202358131751176010.1080/10826084.2023.224707137584436
    [Google Scholar]
32. BenderA. Using Artificial Intelligence for Drug Repurposing.Drug Repurposing. CavallaD. Royal Society of Chemistry2022
    [Google Scholar]
33. RascolO. FabbriM. PoeweW. Amantadine in the treatment of Parkinson’s disease and other movement disorders.Lancet Neurol.202120121048105610.1016/S1474‑4422(21)00249‑034678171
    [Google Scholar]